At NOA, in appropriate circumstances, the physicians can test your tumor for genetic mutations (examples include EGFR, ALK, BRAF, etc.) to enable treatment specific for your individual cancer.
NOA will also consider evaluation of tumors for chemosensitivity, molecular profiling, genetic sequencing, and proteomics to assist in determining targeted therapies or treatments that are cancer specific. This testing further helps the patient and the physician to choose an appropriate chemotherapy regimen that will provide you with maximum benefit and minimize unnecessary toxicity.
NOA utilizes the most modern techniques available (examples include Foundation One, Caris, oncotype DX, etc.) to determine if chemotherapy or some other form of biological therapy is of any potential benefit to the patient.